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Abstract
Introduction: Anaemia and the associated need for packed red blood cell (PRBC) transfusions are common in patients 
admitted to the intensive care unit (ICU). Among many causes, blood losses from repeated diagnostic tests are 
contributory.
Methods: This is a before and after study in a medical ICU of a university hospital. We used a closed blood conservation 
device (Venous Arterial blood Management Protection, VAMP, Edwards Lifesciences, Irvine, CA, USA) to decrease PRBC 
transfusion requirements. We included all adult (≥18 years) patients admitted to the ICU with indwelling arterial 
catheters, who were expected to stay more than 24 hours and were not admitted for active gastrointestinal or any 
other bleeding. We collected data for six months without VAMP (control group) immediately followed by nine months 
(active group) with VAMP. A restrictive transfusion strategy in which clinicians were strongly discouraged from any 
routine transfusions when haemoglobin (Hb) levels were above 7.5 g/dL was adopted during both periods.
Results: Eighty (mean age 61.6 years, 49 male) and 170 patients (mean age 60.5 years, 101 male) were included in the 
control and active groups respectively. The groups were comparable for age, gender, Acute Physiology and Chronic 
Health Evaluation (APACHE) II score, need for renal replacement therapy, length of stay, and Hb levels on discharge and 
at transfusion. The control group had higher Hb levels on admission (12.4 ± 2.5 vs. 11.58 ± 2.8 gm/dL, P = 0.02). Use of a 
blood conservation device was significantly associated with decreased requirements for PRBC transfusion (control 
group 0.131 unit vs. active group 0.068 unit PRBC/patient/day, P = 0.02) on multiple linear regression analysis. The 
control group also had a greater decline in Hb levels (2.13 ± 2.32 vs. 1.44 ± 2.08 gm/dL, P = 0.02) at discharge.
Conclusions: The use of a blood conservation device is associated with 1) reduced PRBC transfusion requirements and 
2) a smaller decrease in Hb levels in the ICU.
Introduction
A significant number of patients in the intensive care unit
(ICU) receive packed red blood cell (PRBC) transfusions
[1]. Anaemia which affects up to 90% of ICU patients by
Day 3 is multifactorial [1]. One such cause is blood loss, up
to 17% of which is contributed by repeated blood drawing
for diagnostic tests [2,3]. Blood samples may be drawn up
to 24 times in a day, resulting in an average blood loss of 41
ml on Day 1 [4]. There is a positive correlation between
organ dysfunction and the number of blood draws [2,3,5].
The presence of indwelling central venous or arterial cathe-
ters makes blood sampling easier but contributes to iatro-
genic anaemia as the first few millilitres of infusate-blood
mixture obtained while collecting blood from such cathe-
ters are discarded [6-8]. In two large trials, 37 to 44% of
patients in ICU received PRBC transfusions [1,5] often at
high transfusion thresholds, despite evidence to support a
restrictive transfusion practice to keep haemoglobin (Hb)
levels in the range of 7 to 9 g/dL [9]. Importantly, PRBC
transfusions are associated with adverse effects, including
allergic, anaphylactic and haemolytic transfusion reactions,
transfusion-related acute lung injury (TRALI), transfusion-
associated circulatory overload (TACO), acute respiratory
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distress syndrome (ARDS), infections, and ventilator-asso-
ciated pneumonia, all of which lead to significant morbidity
and mortality [10-14].
Reduction of the discarded blood volume is possible
using a three-way connection [15] or a dedicated blood con-
servation system [16]. While data exist to show that such
devices may reduce the degree of blood loss [17,18] result-
ing in higher Hb levels [19], no previous study has demon-
strated any significant effect of these devices on the amount
of blood transfusion. This apparent paradox may be related
to the inadequate sample sizes or study design issues
including the lack of standardised thresholds for transfu-
sions [20]. The primary objective of the present study is
therefore to investigate if the use of a blood conservation
device in the presence of a standardised restrictive transfu-
sion practice can reduce the number of units of PRBC trans-
fused. The secondary objective is to investigate if the use of
the device is associated with a smaller decrease in Hb levels
from ICU admission to discharge.
Materials and methods
Study design
This was a before-and-after study conducted in the 12-bed
medical ICU of our university hospital. The before-study
period included patients from January to June 2008 (control
group). The blood conservation device was introduced to
the active group at the start of the after period from July
2008 to March 2009 (active group).
Patients
We included all patients admitted to the ICU who were 1)
18 years and above, 2) expected to stay more than 24 hours
and 3) had an indwelling intra-arterial catheter inserted. We
excluded patients who 1) were expected to stay less than 24
hours and 2) had active gastrointestinal or other bleeding as
the primary cause of ICU admission. Patients were fol-
lowed up till hospital discharge, death or up to 28 days of
ICU stay, whichever was later.
Device
We used the Venous Arterial blood Management Protection
(VAMP) system (Edwards Lifesciences, Irvine, CA, USA)
for the active group. This device has been described previ-
ously [16]. Briefly, it is attached to the existing arterial
catheter. While drawing the samples the flexures of the
device are firmly squeezed and a blood volume is slowly
drawn into the reservoir over three to five seconds. The
shut-off valve just proximal to the reservoir towards the
patient's end is then closed. The sample site is cleaned and a
syringe with a custom-made cannula (Edwards Life-
sciences) is attached. A vacuum tube is attached to the
syringe and the required blood sample(s) is drawn. Follow-
ing the collection of the sample, the syringe with the can-
nula is removed and the shut-off valve is opened. The
device's plunger is then pushed down smoothly and evenly
over three to five seconds, until the flexures lock in place in
the fully closed position and all fluids have been reinfused
into the arterial line. A single device was used for an indi-
vidual arterial catheter throughout the patient's stay and
removed or changed with the arterial catheter.
Transfusion practice
We employed a restrictive transfusion practice in both the
before and after periods of the study [9]. Clinicians were
strongly discouraged against any routine transfusion of
PRBCs when the Hb level was above 7.5 g/dL, unless there
was a physiological need for transfusions (including trans-
fusion as part of resuscitation, preoperatively, or in patients
with coronary artery disease). Ultimately, however, the
decision to transfuse was left to the discretion of the clini-
cians.
Outcomes
The primary outcome was the number of units of PRBC
transfused per patient per day of ICU stay. The secondary
outcome was the difference between the Hb levels at ICU
admission and discharge.
Data collection
We recorded the following data prospectively: patient
demographics, Acute Physiology and Chronic Health Eval-
uation (APACHE) II score, Hb levels at ICU admission and
discharge or death and just before any PRBC transfusion,
number of units of PRBC transfused, need for any renal
replacement therapy (RRT), ICU length of stay (LOS), and
mortality. For the patients who died in ICU, the last Hb
before death was recorded.
Sample size
On a ratio of one control to two active patients, with 80%
power and a two-sided test of 5%, 80 controls to 160
patients will provide a statistically significant result for a
difference of at least 0.05 unit PRBC/patient/day with a
standard deviation of 0.15 units PRBC/patient/day.
Statistical analysis
We expressed variables as means ± standard deviations and
numbers (percentages), and made comparisons using Stu-
dent's t-test and the chi-square test where appropriate. To
elucidate the independent predictors of transfusion require-
ment, the following variables were entered into a linear
regression model: age, gender, Hb on admission and just
before transfusions, LOS, severity of illness, RRT (duration
in hours), and use of the blood conservation device. The
same variables were entered into a separate logistic regres-
sion model to ascertain the independent predictors of ICU
and hospital mortality. We used the statistical software
SPSS version 17.0 (SPSS Inc., Chicago, IL, USA).Mukhopadhyay et al. Critical Care 2010, 14:R7
http://ccforum.com/content/14/1/R7
Page 3 of 7
The study was approved by our Institutional Review
Board and Ethics committee. Informed consent was
obtained in the active group. Requirement of consent was
waived for the control group.
Results
There were 80 patients in the control group and 170 patients
in the active group (Figure 1). There were no significant
differences in age, gender, APACHE II score, and percent-
age of patients requiring RRT in the two groups (Table 1).
There were no complications associated with VAMP
device.
Transfusion and Hb levels
Although baseline Hb levels at admission were signifi-
cantly lower in the active group compared to the control
group, the active group required less PRBC transfusion
(0.068 vs. 0.131 units/patient/day) (Table 2). Analysis by
the linear regression model showed that the use of a blood
conservation device was independently associated with
lower PRBC requirements (P = 0.02, Table 3).
The Hb on admission was significantly higher in the con-
trol group (12.4 ± 2.5 vs. 11.58 ± 2.8, P = 0.02) but were
similar at discharge in both groups. Correspondingly, there
was a smaller drop in Hb levels between admission and dis-
charge in the active group than in the control group (mean
1.44 vs. 2.13 g/dL, P = 0.02, Table 2).
Seventeen (21.3%) patients in the control group received
62 units of PRBC over 42 episodes of transfusion and 52
(30.6%) patients in the active group received 129 units of
PRBC over 84 episodes. The Hb level at transfusion was
above the suggested threshold in 10/42 (23.8%, range 7.6 to
9.2 g/dL) episodes in the control group and 25/84 episodes
(29.7%, range 7.6 to 11 g/dL) in the active group (P = 0.3,
Table 2).
Sixty-three patients in the control and 118 patients in the
active group did not receive any packed cell transfusions
(Table 2). There was no significant difference in the change
in Hb levels from admission to discharge between these
groups.
Mortality and length of stay
ICU (control group 31/80, 38% vs. active group 37/170,
21%, P = 0.001) and hospital (control group 43/80, 53% vs.
active group 51/170, 30%, P = 0.001) mortality were signif-
icantly higher in the control group. Even after adjusting for
other variables including gender, age, RRT, Hb on admis-
sion and at transfusion, LOS and APACHE II score, mortal-
ity in the active group remained significantly less (Table 3).
The ICU LOS was similar in both groups (control group 6.6
± 4.8 vs active group 8.3 ± 8.1 days, P = 0.09).
Discussion
In the present study, patients using a blood conservation
device had a 48% reduction in PRBC transfusion require-
ments. This was not observed in previous studies using sim-
ilar devices. The device was also associated with a smaller
decrease in Hb levels between ICU admission and dis-
charge.
Use of blood conservation devices has been studied pre-
viously. Three-way stopcock and syringes can be used to
preserve the discarded blood-infusate [4]. Silver MJ et al
Figure 1 Patient enrollment. LOS = length of stay.
Control 
group:
106 patients with 
intra-arterial 
catheter
6 patients with 
active bleeding 
excluded
5 patients with 
active bleeding 
excluded
20 patients with 
ICU LOS <24h  
excluded 
56 patients with 
ICU LOS <24h  
excluded 
7 deaths
(28%)
18 deaths
(32%)
Control 
group:
80 patients 
included
Intervention 
group:
170 patients 
included
Intervention 
group:
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intra-arterial 
catheter
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[19] showed that the blood samples obtained with the
blood-conserving arterial line were free of haemodilution or
heparin contamination. In a small randomised control trial
(RCT), Peruzzi WT et al [19] showed that the conservation
group had better preservation of Hb with less volume of
blood being discarded. However, the decrease in the trans-
fusion requirements was not significant. Such devices were
also found to be free of microbial contaminations [21].
Despite their potential benefits, blood conservation
devices are rarely used. In a survey of members of the Soci-
ety of Critical Care Medicine, most agreed that such
devices could be very useful in preventing anaemia [4].
Another survey found that such devices were used in only
18.4% of adult ICUs in England and Wales [22]. One rea-
son for such a paradox is the lack of convincing data on the
effect of these devices on transfusion requirements. Encour-
agingly, findings of the present study strongly suggest that
such devices do indeed reduce PRBC transfusion.
Determination of a transfusion threshold or trigger in the
ICU has been challenging. Due to the adoption of a restric-
tive transfusion practice [9] in our ICU, only 27.6% of our
patient cohort received PRBC transfusions, which is lower
than in previous studies [1,5]. This is reflected in the similar
Hb levels at transfusion in both the control and active (7.1 ±
0.85 vs 7.25 ± 1.1 g/dL) groups. It is likely that concurrent
application of the restrictive transfusion practice where
transfusion triggers are not individualised but guided,
allowed demonstration of the effect of the blood conserva-
tion device on transfusion requirements. This notwithstand-
ing, 23.8% and 29.7% patients in the control and active
group respectively did receive transfusions above the sug-
gested threshold (Table 2). In addition, a relatively smaller
number of patients in the control group (control 17/80,
21.3% vs active 52/170, 30.6%) received a larger number of
PRBC transfusions (control 62 units vs active 129 units of
PRBC, table 2). This suggests that multiple transfusions of
the same patients occurred in the control group.
In our study, the control group had a greater loss of Hb;
this finding is consistent with those of previous studies
[15,18,19]. Patients in the control group had higher Hb lev-
Table 1: Baseline characteristics
Baseline characteristics Control group: without 
blood conservation device 
(n = 80)
Active group: with blood 
conservation device (n = 
170)
P-value
Underlying aetiology
Sepsis 0.71
Pulmonary 28 (35%) 65 (38%)
Extra-pulmonary 18 (22.5%) 31 (18%)
Airway disease 7 (9%) 18 (10.5%) 0.82
Neurological 6 (7.5%) 11 (6.5%) 0.79
Renal failure, Metabolic 
acidosis
5 (6%) 11 (6.5%) 1.0
Acute Pulmonary Odema 5 (6%) 12 (7%) 1.0
Others 11 (14%) 23 (13.5%) 1.0
Age (years) 61.6 ± 18.3 60.5 ± 15.5 0.62
Male/Female 49/31 101/69 0.78
APACHE II score 18.6 ± 7 21.24 ± 7.8 0.09
RRT (%) 21 24 0.4
Hb on admission (g/dL) 12.4 ± 2.5 11.58 ± 2.8 0.02
APACHE = Acute Physiology and Chronic Health Evaluation, RRT = renal replacement therapy, Hb = haemoglobinMukhopadhyay et al. Critical Care 2010, 14:R7
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els on admission but similar Hb levels at discharge from
ICU. There was also a numerical, though not statistically
significant, trend toward better preservation of the Hb at
discharge in the group without transfusion (Table 2).
Patients with the blood conservation device had a signifi-
cantly lower ICU and hospital mortality. While these find-
ings must be interpreted with caution since the present
study was not an RCT and mortality was not our primary or
secondary end-point, they do suggest a protective effect of
reduced transfusion. Indeed, blood transfusion was associ-
ated with higher mortality in both the CRIT and ABC trials
[1,5]. Nonetheless, it should be noted that among the
patients who stayed in the ICU for less than 24 hours, a
larger number of patients died in the active group which
may have contributed to the improved mortality in the
remaining patients.
We acknowledge the limitations of our study. First, this
was a before-and-after study and given the limitations of
historical control study, the results of our study need to be
confirmed with prospective RCT. Second, physicians and
nurses were not blinded to the device. Nonetheless, we
attempted to ensure equal treatment of both groups with the
common restrictive transfusion strategy, which was
reflected by the similar transfusion thresholds between the
two periods. Third, we only included patients admitted to
the medical ICU and expected to stay more than 24 hours.
Although the largest volume of blood is drawn during the
first 24 hours [18], such a short study period may be insuffi-
cient to demonstrate any reduction in the PRBC transfu-
sions. A previous study has shown that the higher mean Hb
in the blood conservation group was statistically significant
only after 9.5 days of ICU stay [19]. Fourth, we excluded
Table 2: Transfusion and haemoglobin levels
Control group: without 
blood conservation device
Active group: with blood 
conservation device
P-value
All patients, n 80 170
PRBC transfusion (unit/
patient/day)
0.131 0.068 0.02*
Hb on admission (g/dL) 12.4 ± 2.5 11.58 ± 2.8 0.02
Hb on discharge (g/dL) 10.2 ± 1.8 10.1 ± 2 0.6
Loss of Hb (g/dL) 2.13 ± 2.32 1.44 ± 2.08 0.02
Patients with transfusion, n 
(%)
17 (21.3) 52 (30.6) 0.12
Hb at transfusion (g/dL) 7.1 ± 0.85 7.25 ± 1.1 0.5
Transfusion above Hb of 
7.5 g/dL (%)
23.8 29.7 0.3
Patients without transfusion, n 
(%)
63(78.7) 118 (69.4) 0.12
Loss of Hb (g/dL) 1.97 ± 2.00 1.83 ± 1.77 0.6
PRBC = packed red blood cell, Hb = haemoglobin
* Adjusted for the variables in Table 3Mukhopadhyay et al. Critical Care 2010, 14:R7
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patients with active bleeding where transfusion practices
may differ. Fifth, we used the VAMP device and it remains
to be seen if our findings are applicable to other blood con-
servation devices.
Conclusions
Since anaemia is the main reason for transfusion in the
ICU, and a blood conservation device is associated with
better preservation of Hb, it is logical that use of such a
device will reduce transfusion requirements. In this before-
and-after study, use of a blood conservation device in the
presence of a restrictive transfusion practice was indeed
associated with a significant reduction in blood transfusion
requirements. The significance of this finding is clear given
the current worldwide shortage of PRBCs, but extends far
beyond apparent cost-benefit ratio and economic savings.
PRBC transfusions are associated with significant morbid-
ity and mortality and any reduction in transfusions may
eventually improve overall patient outcome. A larger pro-
spective RCT is currently being planned.
Table 3: Adjusted estimates for control vs active on PRBC transfusion requirements and mortality outcomes
PRBC 
transfusion 
(unit/patient/
day)
ICU Mortality Hospital 
Mortality
B Estimate 
(95% CI)
P-value OR (95% CI) P-value OR (95% CI) P-value
Control vs 
Active
0.063 (0.010, 
0.116)
0.02 0.34 (0.19, 
0.60)
< 0.001 0.36 (0.20, 
0.63)
< 0.001
Age (years) -0.003 (-0.005, 
-0.002)
< 0.001 0.99 (0.97, 
1.01)
0.268 0.99 (0.98, 
1.01)
0.608
Male vs 
Female
-0.035 (-0.085, 
0.014)
0.158 1.1 (0.61, 1.9) 0.782 1.2 (0.7, 2.1) 0.502
APACHE II 
score
0.003 (-0.001, 
0.007)
0.067 1.01 (0.97, 
1.05)
0.589 1.004 (0.97, 
1.04)
0.82
Hb before 
transfusion (g/
dL)
0.050 (0.041, 
0.059)
< 0.001 0.95 
(0.86,1.05)
0.337 0.98 (0.89, 
1.08)
0.647
Hb on 
admission (g/
dL)
-0.001 (-0.011, 
0.009)
0.842 0.92 
(0.82,1.03)
0.157 0.95 (0.85, 
1.06)
0.331
ICU LOS (days) -0.006 (-0.009, 
-0.002)
0.001 0.99 (0.95, 
1.03)
0.627 0.99 (0.95, 
1.03)
0.616
RRT (Duration, 
hours)
0.0003 (-
0.0001, 0.001)
0.197 1.004 (0.99, 
1.01)
0.176 1.001 (0.99, 
1.007)
0.646
Hb = haemoglobin, ICU = intensive care unit, LOS = length of stay, APACHE = Acute Physiology and Chronic Health Evaluation, RRT = renal 
replacement therapyMukhopadhyay et al. Critical Care 2010, 14:R7
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Key messages
• Anaemia is common in critically ill patients admitted
to ICU and as a result, large numbers of patients receive
blood transfusions.
• Blood transfusions are in short supply, expensive and
have deleterious effects on patient outcome.
• Previous studies have shown that by preserving the
discarded volume of blood from indwelling arterial or
central line catheters, blood conservation devices can
improve anaemia (Hb).
• The present study shows that with restrictive transfu-
sion practice, blood conservation devices can reduce
blood transfusion requirements.
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